Intersect ENT
XENT
#6113
Rank
โ‚ฌ0.79 B
Marketcap
23,59ย โ‚ฌ
Share price
0.00%
Change (1 day)
2.50%
Change (1 year)

Revenue for Intersect ENT (XENT)

Revenue in 2021: โ‚ฌ89.15 Million

According to Intersect ENT's latest financial reports the company's current revenue (TTM ) is โ‚ฌ89.15 Million. In 2021 the company made a revenue of โ‚ฌ89.15 Million an increase over the revenue in the year 2020 that were of โ‚ฌ67.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intersect ENT from 2012 to 2021

Annual revenue

Year Revenue Change
2021โ‚ฌ89.15 M32.52%
2020โ‚ฌ67.27 M-26.19%
2019โ‚ฌ91.15 M0.62%
2018โ‚ฌ90.59 M12.64%
2017โ‚ฌ80.43 M22.35%
2016โ‚ฌ65.73 M27.79%
2015โ‚ฌ51.44 M59.62%
2014โ‚ฌ32.22 M115.2%
2013โ‚ฌ14.97 M205.83%
2012โ‚ฌ4.89 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ocular Therapeutix
OCUL
โ‚ฌ46.58 M-47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
โ‚ฌ6.76 B 7,490.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Anika Therapeutics
ANIK
โ‚ฌ67.57 M-24.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚ฌ1.10 B 1,143.91%๐Ÿ‡บ๐Ÿ‡ธ USA